CClinicalTrials.gg
CompletedNCT02908997Updated Nov 6, 2018

MindMate: A Study of a Reminder System for People With Dementia

An interventional study of MindMate in Dementia, sponsored by NHS Greater Glasgow and Clyde. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-06.

Sponsored by NHS Greater Glasgow and Clyde · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A study to investigate the effectiveness of a reminder tool application at increasing performance on memory tasks in people with mild dementia

Read the detailed description

Background

Memory difficulties are a core feature of dementia. These include difficulties remembering to do something at a specific time and place in the future (Prospective Memory). Although a range of electronic prospective memory aids currently exist (e.g. "Neuropage"), the evidence supporting their use among the dementia population remains limited. "Mindmate" is a recently developed mobile application that aims to support individuals with a diagnosis of dementia, improving self-management skills and quality of life.

Aims

This study will explore the effectiveness of "MindMate" reminder alerts delivered to a smart phone or tablet computer as a memory aid for people with a diagnosis of Mild Dementia.

Method

Three participants with a diagnosis of dementia, who are considered to be in the early stages and who report everyday prospective memory difficulties, will be recruited from Older People Community Mental Health teams within Greater Glasgow and Clyde. The participants will own a smart phone or tablet and will be living with a partner or family member who will also participate in the study. During the initial baseline phase, the partner or family member will monitor the number of pre defined tasks the participant remembered and forgot. The partner or family member will record this information on a weekly monitoring form and this phase will last between five to seven weeks. This will be followed by a five-week intervention phase where "MindMate" reminder alerts will be sent to the participant's phone or tablet. Again, tasks that require remembering will be identified prior to the intervention phase, and family members or carers will monitor their success on a form. Results will be analysed using visual inspection and Tau-U analysis.

Applications

This study will provide information on the effectiveness of a form of assistive technology at supporting people with a dementia, which could improve quality of life of those with a diagnosis.

02

Conditions studied

  • Dementia

Browse trials for

03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 541 are open to participants now.

This study's enrollment of 3 is below the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

NHS Greater Glasgow and Clyde is the lead sponsor of 215 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • has a diagnosis of Mild Dementia, according to International Classification of Diseases (ICD) 10 Criteria
  • has received the diagnosis from a psychiatrist
  • owns a smart phone or tablet
  • has a family member/partner/carer who is willing to monitor memory aid use
  • has capacity to consent to being involved in the research
  • is reporting memory difficulties that are affecting them in daily life

Exclusion criteria

Exclusion Criteria:

  • visual or auditory difficulties which cannot be corrected through the use of appropriate aids
  • has a pre-existing neurological or severe psychiatric problem (e.g. bipolar disorder, psychosis)
  • has a diagnosis of dementia that is considered to be in the moderate to severe stages
  • those whose first language is not English
  • those with a diagnosed or suspected developmental learning disability
  • those who are currently using online or electronic memory aids
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    5 week baseline

    5 week baseline data collection followed by 6 week MindMate intervention

    Other: MindMate

  • Experimental
    6 week baseline

    6 week baseline data collection followed by 6 week MindMate intervention

    Other: MindMate

  • Experimental
    7 week baseline

    7 week baseline data collection followed by 6 week MindMate intervention

    Other: MindMate

Interventions

  • OtherMindMate

    A dementia-specific mobile reminding application

06

What researchers measure

Primary outcomes

  1. Memory

    Number of target events the participant remembered to complete

    Time frame: 6 weeks

Secondary outcomes

  1. Acceptability

    Unified Theory of Acceptance and Use of Technology (UTAUT) questionnaire

    Time frame: Change from baseline to 6 week post-intervention

07

Study locations

1 site
  • NHS Greater Glasgow and Clyde
    Glasgow, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02908997
Lead sponsor
NHS Greater Glasgow and Clyde
Collaborators
University of Glasgow
Responsible party
Sponsor
First posted
Sep 21, 2016
Start date
Jan 17, 2017
Primary completion
Jul 31, 2018
Completion
Jul 31, 2018
Last update
Nov 6, 2018

Study contacts

Jonathan Evans, BSc DClinPsy PhD
principal investigator · University of Glasgow

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion